Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5655 of 5804
-
New blood thinner tested in small chinese heart study
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics (PK), pharmacodynamics, and tolerability of a single dose of selatogrel in Chinese adults with chronic coronary syndrome. Pharmacokinetics is the study of the absorption and breakdown of the study drug in the body. Ph…
Phase: PHASE1 • Sponsor: Viatris Innovation GmbH • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Drug interaction study: bosentan may change zongertinib levels
Knowledge-focused Recruiting nowThe main objective of this trial is to investigate the effect of a moderate CYP 3A inducer bosentan on the pharmacokinetics of zongertinib.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Osteoporosis drug studied for spine surgery recovery – but trial pulled
Disease control TerminatedThe goal of this clinical trial is to learn if romosozumab (Evenity) can improve bone and muscle health in postmenopausal women with osteoporosis who are undergoing lumbar spine surgery. The main questions it aims to answer are: * Does romosozumab improve bone strength and reduc…
Phase: PHASE2 • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Bigger gastric tool tested in tiny trial
Knowledge-focused Not yet recruitingThis study investigates the use of the large diameter ViSiGi LUX ™
Phase: NA • Sponsor: Boehringer Labs LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New liquid painkiller combo for kids enters first human tests
Knowledge-focused Recruiting nowThe purpose of this study will be to characterize the pharmacokinetic (PK) profile of the Fixed-Dose Combination (FDC) IBU 62.5 milligram (mg)/APAP 125 mg per 5 milliliter (mL) suspension in children 6 to 11 years of age, inclusive, to satisfy Pediatric Research Equity Act (PREA)…
Phase: PHASE1 • Sponsor: HALEON • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
First human trial of ENC0653 ointment begins safety testing
Knowledge-focused Recruiting nowThis is a FIH, randomized, double-blind, single-center, placebo-controlled, dose -escalation clinical study to evaluate the safety, tolerability and pharmacokinetics of ENC0653 ointment following single and multiple topical dermal administration in healthy adult subjects. Up to …
Phase: PHASE1 • Sponsor: EnnovaBio • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Healthy volunteers to test liquid Diet's gut effects
Knowledge-focused Recruiting nowThis research study is being conducted to determine the effects of enteral nutrition on healthy people. Enteral nutrition for the purpose of this study refers to the use of a specially developed formula taken by mouth that provides all essential nutrition either in the absence of…
Phase: NA • Sponsor: James Lewis • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New drug HSK56630 tested in humans for first time
Knowledge-focused Recruiting nowThis is a first-in-human, single ascending dose (SAD) study in healthy adult participants. This is a single-center, randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability and PK of HSK56630 in healthy adult participants and preliminarily eval…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Healthy volunteers to test new version of cancer drug
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate whether blood levels of sonrotoclax after administration of a tablet for oral suspension are similar to those observed with the current sonrotoclax tablet. In addition, this study evaluates the effect of food on the absorption of sonrotocl…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New food ingredient BP-CBB put to the test in first human study
Knowledge-focused Recruiting nowThis study is the first-in human study for the food ingredient BP-CBB and aims aims to build on the excellent safety and tolerability observed in the extensive food safety assessment performed for BP-CBB, as well as the consumer experience with using the product, and to set the s…
Phase: NA • Sponsor: Bactolife A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Liquid metformin: a gentler option for diabetes?
Symptom relief Not yet recruitingThis is an open-label, randomized study evaluating the tolerability of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Each participant will receive single oral dos…
Phase: PHASE1 • Sponsor: Aspargo Labs, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Could a zap to the wrist ease stroke stiffness?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if neuromuscular electrical stimulation (NMES) works to treat spasticity in adult patients with spasticity related to stroke. The main question it aims to answer is: • Does NMES reduces the severity of spasticity? Researchers will comp…
Phase: NA • Sponsor: Izmir Katip Celebi University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New drug DA-5223 tested in tiny human trial
Knowledge-focused CompletedThis study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New study to see which breathing tube method causes least sore throat
Knowledge-focused Not yet recruitingBefore surgery, patients will be evaluated by an anesthesiologist at the anesthesia clinic and informed in detail about the study. Patients who do not wish to participate in the study will absolutely not be included, and this will not affect the patients' treatment process in any…
Sponsor: Amasya University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New heart failure drug candidate begins first human tests
Knowledge-focused Recruiting nowThe purpose of this Phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-7156 in healthy participants.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Healthy volunteers test dupilumab shot with enzyme helper
Knowledge-focused OngoingThis is a Phase 1 study with 2 parallel groups of healthy participants. Participants will be randomized to receive either a subcutaneous (SC) dose of dupilumab coformulated with berahyaluronidase alfa or a SC dose of dupilumab without berahyaluronidase alfa. The purpose of this …
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New cholesterol drug candidate tested in healthy volunteers
Knowledge-focused CompletedTo Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
Phase: PHASE1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Healthy volunteers needed for Early-Stage drug safety trial
Knowledge-focused OngoingTo assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Could a single pill replace two? early study tests combo drug
Knowledge-focused Recruiting nowThe purpose of this study is to assess how well laroprovstat and ezetimibe combined in a single tablet to be taken by mouth works and what the body does to the drug (pharmacokinetics) compared with laroprovstat and ezetimibe individual tablets to be taken by mouth (relative bioav…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Eye burn treatment study halted before it began
Disease control TerminatedThe purpose of this study is to evaluate the effectiveness in using subcutaneous 5-FU/Kenalog \& topical Maxitrol Ophthalmic ointment as different therapeutic adjuncts in the prevention of pathologic remodeling after periorbital burns.
Phase: PHASE1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC